New Prospective Study Evaluates the Accuracy of Masimo SpHb® Noninvasive and Continuous Hemoglobin Monitoring During Elective Cesarean Section
Masimo SpHb Demonstrated “Clinically Acceptable Accuracy” of Hemoglobin Measurement, Even at Low Hemoglobin Levels NEUCHATEL, Switzerland–(BUSINESS WIRE)– Masimo (NASDAQ: MASI) today announced the findings of...